Key result
AIM2 upregulation links to an immunosuppressive microenvironment and poorer prognosis in lung adenocarcinoma.
Observational
Answers are grounded in this paper and cite their sources.
Reveals that elevated AIM2 expression promotes an immunosuppressive microenvironment in lung adenocarcinoma, indicating a pathway linked to poor patient prognosis.
The absent in melanoma 2 (AIM2) inflammasome has been demonstrated as involved in tumor growth. In this study we used human samples of lung adenocarcinoma (LUAD) patients, taking advantage of a mouse model of smoking cessation. Human samples were stratified according to the smoking status, high-risk factor for this type of tumor. Both public transcriptomic and human samples obtained by a clinical trial proved that AIM2 was upregulated either in terms of mRNA or protein, respectively, in the tumor mass according to the TNM stage, but it did not relate to the smoking status, age and sex. The upregulation of AIM2 was correlated to an immunosuppressive environment according to resting/non-active dendritic cells (DCs) and T regulatory cells, as demonstrated in both human samples and by means of an experimental model of smoking mice. Computational analysis showed that AIM2 upregulation was correlated to both an inflammasome profile, responsible for the poor prognosis of non-smoker and smoker LUAD patients, and to a non-inflammasome profile for former smoker. In conclusion, our study demonstrated that AIM2 is involved in lung carcinogenesis either in a canonical and non-canonical manner due to an immunosuppressive microenvironment associated to a dismal prognosis of LUAD patients.
No takes yet. Share an insight, caveat, or question.
Colarusso et al. (2023) conducted an observational in Lung adenocarcinoma (LUAD). AIM2 (Absent in melanoma 2) upregulation and smoking status vs. Lower AIM2 expression / non-smokers and former smokers was evaluated on AIM2 expression, immunosuppressive tumor microenvironment, and prognosis in lung adenocarcinoma. AIM2 upregulation in lung adenocarcinoma correlated with TNM stage, an immunosuppressive microenvironment (resting DCs and Tregs), and poor prognosis regardless of smoking status.
Synapse has enriched 10 related papers. Consider them for comparative context: